CLEARSIDE BIOMEDICAL
Clearside BioMedical, an ophthalmic company, specializes in the research, development, and commercialization of therapeutic products through an ocular microinjection platform that targets the individual compartments of the eye. It provides a non-surgical application for dosing drugs to distinct eye tissues, such as the retina, trabecular meshwork, and corneal stroma. The company’s CLS1001 is under development for retinal applications through the delivery of therapeutics to the suprachoroidal space. Clearside BioMedical was incorporated in 2011 and is based in Atlanta, Georgia.
CLEARSIDE BIOMEDICAL
Industry:
Biotechnology Health Care Medical Device Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
Alpharetta, Georgia, United States
Country:
United States
Website Url:
http://www.clearsidebio.com
Total Employee:
11+
Status:
Active
Contact:
(678)270-3631
Email Addresses:
[email protected]
Total Funding:
188.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Wordpress Plugins Global Site Tag
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Cellular Biomedicine Group
CBMG is a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies.
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
HealthCare Royalty Partners
HealthCare Royalty Partners investment in Post-IPO Debt - Clearside Biomedical
RMI Partners
RMI Partners investment in Funding Round - Clearside Biomedical
Aju IB Investment
Aju IB Investment investment in Series C - Clearside Biomedical
Rock Springs Capital
Rock Springs Capital investment in Series C - Clearside Biomedical
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Clearside Biomedical
Perceptive Advisors
Perceptive Advisors investment in Series C - Clearside Biomedical
Mountain Group Capital
Mountain Group Capital investment in Series B - Clearside Biomedical
RMI Partners
RMI Partners investment in Series B - Clearside Biomedical
Hatteras Venture Partners
Hatteras Venture Partners investment in Series B - Clearside Biomedical
Georgia Research Alliance
Georgia Research Alliance investment in Series B - Clearside Biomedical
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-14 | Clearside Biomedical Expands Leadership Team with Appointment of Susan Coultas, Ph.D., as Chief Clinical Officer |
Official Site Inspections
http://www.clearsidebio.com Semrush global rank: 1.15 M Semrush visits lastest month: 27.52 K
- Host name: 212.87.134.34.bc.googleusercontent.com
- IP address: 34.134.87.212
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Clearside Biomedical"
Corporate Overview – Clearside Biomedical
Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®).Clearside’s SCS injection platform, utilizing the Company’s patented …See details»
Clearside Biomedical - Crunchbase Company Profile
Contact Email [email protected] Phone Number (678)270-3631 Clearside BioMedical, an ophthalmic company, specializes in the research, development, and commercialization of therapeutic products through an ocular …See details»
Contact – Clearside Biomedical
LET'S GET THE CONVERSATION GOING Headquarters Clearside Biomedical 900 North Point Parkway Suite 200 Alpharetta, GA 30005 Main: (678) 270-3631 Fax: (678) 270-4033 …See details»
Clearside Biomedical, Inc. | LinkedIn
Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®). Clearside’s SCS …See details»
Clearside Biomedical Further Strengthens Commercial …
ALPHARETTA, Ga., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD), a biopharmaceutical company dedicated to developing treatments that …See details»
Clearside Biomedical - Overview, News & Similar companies
May 9, 2024 Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024 ALPHARETTA, Ga., April 30, 2024 (GLOBE …See details»
Clearside Biomedical, Inc. (CLSD) Company Profile & Overview
Jun 2, 2016 Ticker Symbol: CLSD: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001539029: CUSIP Number: 185063104: ISIN …See details»
Clearside Biomedical Announces First Quarter 2024 Financial …
Clearside Biomedical, Inc. - Phase 2b ODYSSEY Trial in Wet AMD Remains on Track with Topline Data Expected Q3 2024 - - Strengthened Management Team and Board of Directors …See details»
Clearside Biomedical - Craft
Oct 29, 2024 Clearside Biomedical has 4 employees at their 1 location and $8.23 m in annual revenue in FY 2023. See insights on Clearside Biomedical including office locations, …See details»
News Release Details - Clearside Biomedical, Inc.- IR Site
Santen researches, develops, and markets ophthalmic products worldwide. Santen has subsidiaries in the U.S., Europe, and Asia, including its wholly owned California-based …See details»
News Release Details - Clearside Biomedical, Inc.- IR Site
Jun 30, 2023 Clearside received the International Organization for Standardization (ISO) Certification EN ISO 13485:2016 for “The design, development, and manufacture of sterile …See details»
Clearside Biomedical Further Strengthens Commercial
Sep 6, 2018 Clearside Biomedical Further Strengthens Commercial Organization With Appointment of Lester Rodríguez as Vice President, Quality September 06, 2018 16:30 ET | …See details»
Working At Clearside Biomedical: Company Overview and Culture
Www.clearsidebio.com. Organization Type. Public. Social Media. Clearside BioMedical, an ophthalmic company, specializes in the research, development, and commercialization of …See details»
How Does Clearside Biomedical Work? – CBM
Nov 15, 2024 Clearside Biomedical is a cutting-edge biopharmaceutical company that uses innovative techniques to deliver treatments to the back of the eye, primarily focusing on …See details»
News Release Details - Clearside Biomedical, Inc.- IR Site
Dec 31, 2023 [email protected] (678) 430-8206. CLEARSIDE BIOMEDICAL, INC. Selected Financial Data (in thousands, except share and per share data) (unaudited) Statements of …See details»
Technology – Clearside Biomedical
Technology clearsidebio 2023-12-09T01:56:25+00:00. Developing and Delivering Treatments that Restore and Preserve Vision for People with Serious Back of the Eye Diseases. Versatile …See details»
Clearside Biomedical, Inc. - Cruelty Free Investing
Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which develops drug therapies to treat chronic, blinding diseases of the eye, with a particular emphasis on diseases …See details»
Products – Clearside Biomedical
Products clearsidebio 2022-05-22T00:14:42+00:00. LEARN MORE (678) 270-3631 [email protected] CONTACT US. ABOUT US MANAGEMENT BOARD OF DIRECTORS …See details»
Pipeline - Clearside Biomedical
Footnotes: 1 XIPERE® (triamcinolone acetonide injectable suspension), for suprachoroidal use has received U.S. FDA Approval and is being commercialized by Bausch + Lomb.. 2 In China, …See details»